JPRN-UMIN000000691UnknownPhase 2
The Study on Appropriate Strategy of Transfusion in Cardiovascular Surgery: a multicenter randomized controlled trial. - ASTRACS Study
ational Cardiovascular Center0 sites100 target enrollmentStarted: May 1, 2007Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 2
- Sponsor
- Enrollment
- 100
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 90years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The Patient has a congenital bleeding tendency The patient has chronic thrombocytopenia (defined as a platelet count <100,000/uL for more than 30 days) The patient has anemia (defined as a hemoglobin level <8.0g/dL) The patient possesses an anti-HLA or anti-platelet antibody, resulting in platelet refractoriness It is highly possible to complete the surgery of the patient without any transfusion in the judgement of the investigator. The patient is inappropriate for entry onto this study in the judgment of the investigator.
Investigators
Similar Trials
Completed
Not Applicable
Transfusion Trigger After Operations in High Cardiac Risk PatientsMyocardial InfarctionCoronary RevascularizationAcute Renal FailureNCT03229941VA Office of Research and Development1,424
Not yet recruiting
Not Applicable
Comparing the efficacy of existing transfusion protocols in massively bleeding patientsCTRI/2018/10/016141A
Recruiting
Not Applicable
REMOTE 2NL-OMON23694non24
Recruiting
Not Applicable
Comparison of different transfusion strategies for red blood cell transfusion dependent MDS and MPN patients - a cross-over study with remote patient monitoringchronic anemiaMDS10002086NL-OMON52859eids Universitair Medisch Centrum24
Active, not recruiting
Phase 3
pper digestive tract bleeding-how much blood to transfuse?CTRI/2017/09/009682Jawaharlal Institute of Post Graduate Medical Education and Research224